Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
Could a painkiller help IPF patients breathe easier?
Symptom relief Recruiting nowThis early-stage study tests a drug called nalbuphine ER in 10 adults with idiopathic pulmonary fibrosis (IPF), a condition that scars the lungs and makes breathing hard. The goal is to see if the drug is safe and can improve breathing function. Participants will take increasing …
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
Breakfast vs. pill: study reveals how a fatty meal changes drug absorption
Knowledge-focused Recruiting nowThis study looks at how a high-fat, high-calorie meal changes the way the body absorbs nalbuphine extended-release tablets. Sixty healthy adults will take the drug once with food and once without, and researchers will compare the levels in their blood. The goal is simply to under…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC